1. A6.7 Evaluation of porphyromonas gingivalis serology in rheumatic and non-rheumatic inflammatory disease. (31st January 2014) Authors: Rinaudo-Gaujous, M; Moreau, A; Blasco-Baque, V; Roblin, X; Genin, C; Thomas, T; Paul, S; Marotte, H Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 1(2014) Page Start: A73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study. (22nd February 2019) Authors: Pineton de Chambrun, G; Pariente, B; Seksik, P; Altwegg, R; Vuitton, L; Stefasnescu, C; Nancey, S; Aubourg, A; Serrero, M; Peyrin-Biroulet, L; Filippi, J; Viennot, S; Abitbol, V; Boualit, M; Boureille, A; Moreau, J; Buisson, A; Roblin, X; Nachury, M; Zappa, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP001 Effectiveness and safety of vedolizumab in anti-TNF naïve patients with inflammatory bowel disease: a multicentre retrospective European Crohn's and Colitis Organisation study. (16th January 2018) Authors: Kopylov, U; Verstockt, B; Biedermann, L; Sebastian, S; Pugliese, D; Sonnenberg, E; Steinhagen, P R; Arebi, N; Ron, Y; Kucharzik, T; Roblin, X; Ungar, B; Bar-Gil Shitrit, A; Ardizzone, S; Molander, P; Coletta, M; Peyrin-Biroulet, L; Bossuyt, P; Avni-Biron, I; Tsoukal, E I Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DOP36 Efficacy and safety of vedolizumab in patients with chronic active pouchitis refractory to anti-TNF therapy: Results of a retrospective multicenter study. (21st January 2022) Authors: Sallette, M; Bouhnik, Y; Nachury, M; Bellanger, C; Laharie, D; Amiot, A; Peyrin-Biroulet, L; Roblin, X; Altwegg, R; Buisson, A; Reenaers, C; Bouguen, G; Vuitton, L; Bourreille, A; Gilletta, C; Serrero, M; Hébuterne, X; Filippi, J Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DOP63 Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multi-centre, prospective, observational cohort study. (22nd February 2019) Authors: Pineton de Chambrun, G; Pariente, B; Seksik, P; Altwegg, R; Vuitton, L; Stefasnescu, C; Nancey, S; Aubourg, A; Serrero, M; Peyrin-Biroulet, L; Filippi, J; Viennot, S; Abitbol, V; Boualit, M; Boureille, A; Moreau, J; Buisson, A; Roblin, X; Nachury, M; Zappa, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S614 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DOP73 A comparative efficacy and safety analysis of subcutaneous infliximab and vedolizumab in patients with Crohn's Disease and Ulcerative Colitis. (21st January 2022) Authors: Peyrin-Biroulet, L; Arkkila, P; Armuzzi, A; Atreya, R; Danese, S; Ferrante, M; Guardiola, J; Jahnsen, J; Louis, E; Lukáš, M; Reinisch, W; Roblin, X; Smith, P J; Kwon, T S; Kim, J Y; Yoon, S W; Kim, D H Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. DOP80 Oral curcumin is not more effective than placebo to prevent endoscopic postoperative recurrence in patients with Crohn's disease treated with concomitant thiopurines: the POPCUR trial. (25th January 2019) Authors: Buisson, A; Laharie, D; Nancey, S; Hébuterne, X; Roblin, X; Nachury, M; Peyrin-Biroulet, L; Fumery, M; Goutorbe, F; Coban, D; Allimant, C; Reymond, M; Vazeille, E; Pereira, B; Goutte, M; Bommelaer, G Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S078 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. DOP85 Efficacy of risankizumab rescue therapy in patients with moderately to severely active Crohn's Disease and inadequate response to risankizumab maintenance therapy. (21st January 2022) Authors: Baert, F J; Atreya, R; Kakuta, Y; Long, M; Roblin, X; Neimark, E; Song, A; Wallace, K; Kingys, K; Mallick, M; Liao, X; Lim, A Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study. (26th February 2022) Authors: Cottron, C; Treton, X; Altwegg, R; Reenaers, C; Amiot, A; Fumery, M; Vuitton, L; Peyrin-Biroulet, L; Bouguen, G; Dewit, O; Nancey, S; Caillo, L; Roblin, X; Beylot-Barry, M; Rivière, P; Laharie, D Journal: Journal of Crohn's and colitis Issue: Volume 16:Number 8(2022) Page Start: 1202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of an Education Programme on IBD Patients' Skills: Results of a Randomised Controlled Multicentre Study [ECIPE]. (24th September 2020) Authors: Moreau, J; Hammoudi, N; Marthey, L; Trang-Poisson, C; Nachury, M; Altwegg, R; Grimaud, J C; Orempuller, S; Hébuterne, X; Aubourg, A; Baudry, C; Seksik, P; Roblin, X; Nahon, S; Savoye, G; Mesnard, B; Stefanescu, C; Simon, M; Coffin, B; Fumery, M Journal: Journal of Crohn's and colitis Issue: Volume 15:Number 3(2021) Page Start: 432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗